Genesee Capital Advisors LLC lifted its position in Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report) by 9.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,826 shares of the financial services provider’s stock after acquiring an additional 332 shares during the period. Genesee Capital Advisors LLC’s holdings in Marsh & McLennan Companies were worth $934,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also recently made changes to their positions in MMC. Ameriflex Group Inc. purchased a new stake in Marsh & McLennan Companies in the fourth quarter valued at $37,000. City Holding Co. purchased a new stake in Marsh & McLennan Companies in the first quarter valued at $37,000. Transce3nd LLC purchased a new stake in Marsh & McLennan Companies in the fourth quarter valued at $39,000. Garde Capital Inc. purchased a new stake in Marsh & McLennan Companies in the first quarter valued at $42,000. Finally, Halbert Hargrove Global Advisors LLC purchased a new stake in Marsh & McLennan Companies in the fourth quarter valued at $45,000. 87.99% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
MMC has been the topic of several recent research reports. Barclays upped their price target on shares of Marsh & McLennan Companies from $246.00 to $249.00 and gave the company an “equal weight” rating in a report on Friday, April 11th. UBS Group upped their price target on shares of Marsh & McLennan Companies from $259.00 to $261.00 and gave the company a “buy” rating in a report on Wednesday, April 9th. Wells Fargo & Company upped their price target on shares of Marsh & McLennan Companies from $223.00 to $232.00 and gave the company an “equal weight” rating in a report on Thursday, April 10th. Redburn Atlantic assumed coverage on shares of Marsh & McLennan Companies in a research note on Tuesday, March 25th. They set a “buy” rating and a $281.00 target price on the stock. Finally, Keefe, Bruyette & Woods lowered their target price on shares of Marsh & McLennan Companies from $220.00 to $215.00 and set an “underperform” rating on the stock in a research note on Monday, April 21st. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $241.93.
Marsh & McLennan Companies Stock Up 1.0%
MMC opened at $216.41 on Friday. Marsh & McLennan Companies, Inc. has a twelve month low of $207.21 and a twelve month high of $248.00. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 1.32. The company has a 50-day moving average price of $225.13 and a 200 day moving average price of $224.77. The company has a market cap of $106.63 billion, a PE ratio of 26.52, a price-to-earnings-growth ratio of 2.65 and a beta of 0.83.
Marsh & McLennan Companies (NYSE:MMC – Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The financial services provider reported $3.06 earnings per share for the quarter, topping the consensus estimate of $3.02 by $0.04. Marsh & McLennan Companies had a net margin of 16.13% and a return on equity of 32.19%. The firm had revenue of $6.70 billion during the quarter, compared to the consensus estimate of $7.08 billion. During the same quarter in the prior year, the firm earned $2.89 EPS. Sell-side analysts expect that Marsh & McLennan Companies, Inc. will post 9.61 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, SVP Paul Beswick sold 2,237 shares of the company’s stock in a transaction dated Thursday, April 3rd. The shares were sold at an average price of $246.00, for a total transaction of $550,302.00. Following the completion of the transaction, the senior vice president now owns 13,522 shares in the company, valued at $3,326,412. This represents a 14.20% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Dean Michael Klisura sold 9,569 shares of the stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $245.00, for a total transaction of $2,344,405.00. Following the completion of the sale, the chief executive officer now owns 20,935 shares of the company’s stock, valued at approximately $5,129,075. The trade was a 31.37% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
See Also
- Five stocks we like better than Marsh & McLennan Companies
- How to find penny stocks to invest and trade
- GE Aerospace Turns Engines Into Long-Term Profits
- What is a Dividend King?
- Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes
- Technology Stocks Explained: Here’s What to Know About Tech
- Marvell’s New AI Chip Deals Capture Wall Street’s Attention
Want to see what other hedge funds are holding MMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.